On November 18, UiPath fell 4.12% in Regular Trading, trading at $11.95 per share, with turnover of $18.7909 million.
Public information available around the move did not show a new company-specific catalyst directly tied to the decline. The stock’s weakness appeared to extend recent divergence within software names rather than reflect a fresh announcement.
Recent developments around UiPath were not new to this session, including its launch-partner role for Google Cloud’s Gemini for healthcare announced earlier in November and prior AI automation collaboration expansions with Snowflake and BDO. Analyst sentiment had also turned more cautious in prior months, with several price-target cuts and underperform or neutral views, while the market remains watchful on the pace of UiPath’s transition from core RPA toward broader business orchestration and AI automation.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments